News Daily News Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care Shelley Wood September 22, 2020
News Daily News In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out Shelley Wood September 18, 2020
News Conference News ESC 2020 Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF Michael O'Riordan August 31, 2020
News Conference News ESC 2020 PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF Todd Neale August 30, 2020
News Conference News ESC 2020 EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF Michael O'Riordan August 28, 2020
News Conference News ESC 2020 More Than Half of Patients See a GP in the 2 Weeks Before OHCA Yael L. Maxwell August 28, 2020
News Daily News Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality Shelley Wood August 19, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News Signs of Cardiac Damage Even in Younger, Nonhospitalized COVID-19 Patients Shelley Wood July 29, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020
News Conference News TVT 2020 MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT Michael O'Riordan June 21, 2020
News Conference News HRS 2020 Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’ Michael O'Riordan May 21, 2020
News Daily News FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction Shelley Wood May 06, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers Michael O'Riordan April 15, 2020
News Daily News Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians Caitlin E. Cox April 09, 2020
News Conference News ACC 2020 A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA Michael O'Riordan March 28, 2020